gynecologic cancer

Shachar EK, Silverstein J, Kwan L, Salani R, Karlan BY, Chase DM. Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? Gynecol[...]

Ramsey-Hardy C, Abel EA, Skanderson M, Akgün KM, Bastian LA, Bean-Mayberry B, Brandt CA, DeRycke EC, Farmer MM, Masheb RM, Murthy SS, Haskell SG, Gaffey[...]

Silverstein J, Smick A, Johnson B, Konecny GE. Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Future Oncol. 2025[...]